Re: FDA approves thrice weekly Copaxone At least this came out as they expected... Didn't say anything on pricing but they still think they can switch large part of patients (30-40% until May and even 45% in 6 months).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.